Invention Grant
- Patent Title: Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases
- Patent Title (中): 用于治疗退行性和炎性疾病的取代三唑并吡嗪
-
Application No.: US12436219Application Date: 2009-05-06
-
Publication No.: US08012983B2Publication Date: 2011-09-06
- Inventor: Martin James Inglis Andrews , Mark Stuart Chambers , Hervé Van De Poël , Grégory Louis Joseph Bar
- Applicant: Martin James Inglis Andrews , Mark Stuart Chambers , Hervé Van De Poël , Grégory Louis Joseph Bar
- Applicant Address: BE Mechelen
- Assignee: Galapagos NV
- Current Assignee: Galapagos NV
- Current Assignee Address: BE Mechelen
- Agency: Klauber & Jackson LLC
- Main IPC: A61K31/4965
- IPC: A61K31/4965
Abstract:
Novel [1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
Public/Granted literature
- US20090286798A1 FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES Public/Granted day:2009-11-19
Information query
